Luis Borges - 03 Apr 2023 Form 4 Insider Report for Century Therapeutics, Inc. (IPSC)

Reporting relationship: Chief Scientific Officer
Issuer ticker: IPSC
Reported as of: 03 Apr 2023
Net transaction value: +$7,676
SEC form: 4
Accepted by SEC: 05 Apr 2023, 16:27:19 UTC
Prior SEC filing: 23 Mar 2023
Next SEC filing: 08 Feb 2024
Source filing: View source filing
Reporting owner signature: /s/ Michael Diem, Attorney-in-Fact

Key filing fact

Luis Borges filed Form 4 for Century Therapeutics, Inc. (IPSC) on 05 Apr 2023.

Key facts

This page summarizes Luis Borges's Form 4 filing for Century Therapeutics, Inc. (IPSC).
2 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 05 Apr 2023, 16:27.

Change

Previous filing in this sequence was filed on 23 Mar 2023.
Current net transaction value: +$7,676.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

IPSC transaction

Common Stock

Options Exercise

Transaction value: $7,676
Shares: +7,452
Change %: +3%
Price: $1.03
Shares after: 256,535
Date: 03 Apr 2023
Ownership: Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

IPSC transaction Derivative

Stock Option (right to buy)

Options Exercise

Transaction value: $0
Shares: -7,452
Change %: -100%
Price: $0.000000^*
Shares after: 0
Date: 03 Apr 2023
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 7,452
Exercise price: $1.03
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

As of the date hereof, these stock options are vested and currently exercisable.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .